Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00241748 · ClinicalTrials.gov registry record
Pharmacoepidemiology and Pharmacogenetics of a Statin Adverse Event
A clinical trial of Rhabdomyolysis, sponsored by University of Washington.
- Completed
- Registry status
- 187
- Enrollment target
- 1
- Study location
NCT00241748: Completed study of Rhabdomyolysis, sponsored by University of Washington.
NCT00241748 is a study of Rhabdomyolysis that has completed, run by University of Washington. The registered enrollment target is 187 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00241748, a study of Rhabdomyolysis, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- 187 participants
- Enrollment target
- 1
- Study location
Study Summary
To conduct a case-control study of factors that increased the risk of rhabdomyolysis, an adverse drug reaction in cerivastatin users
Conditions Studied
Study Locations (1)
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 187 participants |
| Start Date | 2005-09 |
| Est. Completion | 2011-12 |
What the finished NCT00241748 record still lists
NCT00241748 is an observational study that tracks outcomes without assigning an intervention. The registered 187 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Rhabdomyolysis appearing as the primary indexed condition, and to 0 interventions.
NCT00241748 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT00241748 about?
NCT00241748 is a clinical study titled "Pharmacoepidemiology and Pharmacogenetics of a Statin Adverse Event". To conduct a case-control study of factors that increased the risk of rhabdomyolysis, an adverse drug reaction in cerivastatin users
What is the current status of trial NCT00241748?
This trial is currently completed. The enrollment target is 187 participants. The study started on 2005-09. Estimated completion is 2011-12.
What conditions does trial NCT00241748 study?
This clinical trial studies the following conditions: Rhabdomyolysis.
Who is sponsoring clinical trial NCT00241748?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00241748 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rhabdomyolysis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06153251 · 187 participants · Phase 1
A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma
- NCT06254898 · 187 participants · NA
Use of Incentives for Stressful Medical Procedures
- NCT07062237 · 187 participants · NA
A Randomized Clinical Trial Comparing Embryo Euploidy Rates Following Ultrashort Versus Standard Abstinence
- NCT07217574 · 187 participants
Program in Oncology for Tribal Health Systems.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia